Find Grant Opportunities!

Pfizer

RFP jointly issued with Smoking Cessation Leadership Center at UCSF: Smoking Cessation Conference The Smoking Cessation Leadership Center (SCLC) at the University of California in San Francisco and Pfizer Independent Grants for Learning & Change (IGL&C) began collaborating in 2012 to offer new grant opportunities focused on smoking cessation training for healthcare professionals. As a result of that collaboration, following an initial RFP, thirty-nine proposals were funded totaling $4.5 million in awards. This current RFP is being issued with the intent of funding one organization to organize a conference for the organizations that received the 2012 grants, as well as other organizations working in the field, which may or may not have previously been supported by Pfizer or the SCLC.
Women's Health Platform The intent is to support programs that focus on ensuring that patients with rheumatoid arthritis who are starting treatment with or are already being treated with disease-modifying anti-rheumatic drugs (DMARDs) are receiving appropriate vaccines for adults (determined by their age, gender, and specific clinical risk information such as having an immunocompromising condition like RA and going on immunomodulatory or immunosuppressant medications).
IGL&C Extension Grant Procedure for Continuation and/or Expansion of an Existing Grant-supported Initiative Where Additional Funding is Requested